生物防禦市場規模、佔有率、成長分析（按產品、應用、最終用戶、地區）- 2025 年至 2032 年產業預測

2023 年全球生物防禦市場規模為 144 億美元，預計將從 2024 年的 152.9 億美元成長到 2032 年的 247.4 億美元，預測期內（2025-2032 年）的複合年成長率為 6.2%。

生物防禦市場的成長受到政府強力的舉措、私人投資的活性化以及針對流感、茲卡和伊波拉出血熱等流行病的生物防禦戰略支出增加的推動。基因工程和生物技術的最新進展使得修改致命病毒成為可能，這引發了人們對潛在生物武器威脅的擔憂。針對過去曾被用於生物恐怖主義的各種生物製藥，如炭疽菌和肉毒桿菌，世界各國政府都採取了嚴格的措施、條約和政策來對抗生物威脅並最大限度地降低風險。自2001年炭疽菌襲擊事件以來，國家感染疾病研究所在感染疾病研究中發揮了關鍵作用，並為開發醫療產品和打擊生物恐怖主義的策略做出了貢獻，凸顯了市場對全球衛生安全的重要性。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術分析

生物防禦市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 疫苗
  • 炭疽菌
  • 天花
  • 肉毒桿菌中毒
  • 其他
• 生物威脅偵測裝置
  • 採樣器
  • 檢測器/觸發裝置
  • 識別符
  • 檢測方法和試劑

生物防禦市場規模（依應用）及複合年成長率（2025-2032）

• 市場概覽
• 軍隊
• 平民

生物防禦市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院和診所
• 門診治療中心
• 其他

生物防禦市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Emergent BioSolutions Inc.（United States）
• SIGA Technologies, Inc.（United States）
• Dynavax Technologies Corporation（United States）
• Altimmune Inc.（United States）
• XOMA Corporation（United States）
• Cleveland BioLabs Inc.（United States）
• Ichor Medical Systems, Inc.（United States）
• ANP Technologies, Inc.（United States）
• PositiveID Corporation（United States）
• Alexeter Technologies LLC（United States）
• BioFire Defense（bioMerieux SA）（United States）
• Elusys Therapeutics Inc.（United States）
• Battelle National Biodefense Institute, LLC（United States）
• Gryphon Scientific LLC（United States）
• BioRisk Reduction（United States）
• CBRNe Science and Consequence Management World Congress（United States）
• Mammoth Biosciences（United States）
• Alnylam Pharmaceuticals Inc.（United States）
• Bruker Detection（United States）
• New Horizon Diagnostic Corp.（United States）

結論和建議

Global Biodefense Market size was valued at USD 14.4 billion in 2023 and is poised to grow from USD 15.29 billion in 2024 to USD 24.74 billion by 2032, growing at a CAGR of 6.2% during the forecast period (2025-2032).

The growth of the biodefense market is fueled by robust government initiatives, heightened private investments, and increased spending focused on biodefense strategies in response to outbreaks like flu, Zika, and Ebola. Recent technological advancements in genetic engineering and biotechnology enable the modification of deadly viruses, raising concerns about potential bioweapon threats. With various biological agents previously used in bioterrorism-such as anthrax and botulism-governments worldwide are adopting stringent biodefense measures, treaties, and policies to combat biological threats and minimize risks. The National Institute of Infectious Disease plays a crucial role in researching infectious diseases, contributing to the development of medical products and strategies to tackle bioterrorism since the 2001 anthrax attacks, underscoring the market's significance in global health security.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biodefense market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biodefense Market Segments Analysis

Global Biodefense Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Vaccines and Biothreat Detection Devices. Based on Application, the market is segmented into Military and Civilian. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biodefense Market

The Global Biodefense market is significantly driven by substantial investments from federal and state governments aimed at enhancing national and public health security. These expenditures are essential for the development of vaccines, diagnostics, and treatments that ensure healthcare systems are well-prepared for potential biological threats. Furthermore, governments are channeling funds into emergency planning, infrastructure, and training, creating an environment conducive to the advancement of innovative biodefense strategies. This proactive approach not only bolsters preparedness against biological attacks but also strengthens resilience in the face of pandemics, thereby significantly influencing market growth and development.

Restraints in the Global Biodefense Market

The global biodefense market faces significant challenges due to intense competition among established companies, which can result in price wars and diminished profit margins. This competitive landscape poses barriers for new entrants seeking to penetrate the market. Larger enterprises typically wield considerable resources and maintain established connections with regulatory authorities, allowing them to exert substantial influence. To safeguard their market share, these dominant firms may adopt aggressive pricing strategies that not only compress profits but also stifle the growth potential of smaller companies. Consequently, this dynamic creates a challenging environment for emerging players in the vital biodefense sector.

Market Trends of the Global Biodefense Market

The Global Biodefense market is increasingly influenced by the rising trend of personalized medicine, which focuses on developing customized vaccines and treatments tailored to specific demographics and biological threats. This innovative approach enhances response mechanisms to infectious diseases, allowing for more effective public health strategies. As advancements in genomics and biotechnology progress, researchers anticipate the creation of highly effective vaccines designed to align with the unique genetic profiles of diverse populations. Consequently, this trend not only promises to improve individual health outcomes but also strengthens national biodefense strategies by enabling targeted and efficient responses to emerging infectious threats.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Biodefense Market Size by Product & CAGR (2025-2032)

• Market Overview
• Vaccines
  • Anthrax
  • Smallpox
  • Botulism
  • Others
• Biothreat Detection Devices
  • Samplers
  • Detectors/Triggering Devices
  • Identifiers
  • Assays and Reagents

Global Biodefense Market Size by Application & CAGR (2025-2032)

• Market Overview
• Military
• Civilian

Global Biodefense Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Global Biodefense Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Emergent BioSolutions Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIGA Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altimmune Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• XOMA Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleveland BioLabs Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ichor Medical Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANP Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PositiveID Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alexeter Technologies LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioFire Defense (bioMerieux SA) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elusys Therapeutics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Battelle National Biodefense Institute, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gryphon Scientific LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioRisk Reduction (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CBRNe Science and Consequence Management World Congress (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alnylam Pharmaceuticals Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Detection (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New Horizon Diagnostic Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations